US3194732A - Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor - Google Patents
Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor Download PDFInfo
- Publication number
- US3194732A US3194732A US59804A US5980460A US3194732A US 3194732 A US3194732 A US 3194732A US 59804 A US59804 A US 59804A US 5980460 A US5980460 A US 5980460A US 3194732 A US3194732 A US 3194732A
- Authority
- US
- United States
- Prior art keywords
- egg
- shell
- membrane
- fibrous
- shell membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940012466 egg shell membrane Drugs 0.000 title claims description 95
- 230000035876 healing Effects 0.000 title description 17
- 239000000203 mixture Substances 0.000 title description 15
- 239000002245 particle Substances 0.000 claims description 29
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000000047 product Substances 0.000 description 65
- 210000004379 membrane Anatomy 0.000 description 64
- 239000012528 membrane Substances 0.000 description 64
- 210000003278 egg shell Anatomy 0.000 description 35
- 239000000463 material Substances 0.000 description 35
- 238000000034 method Methods 0.000 description 35
- 230000003902 lesion Effects 0.000 description 23
- 210000003491 skin Anatomy 0.000 description 22
- 239000000835 fiber Substances 0.000 description 21
- 102000002322 Egg Proteins Human genes 0.000 description 20
- 108010000912 Egg Proteins Proteins 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000007788 liquid Substances 0.000 description 19
- 239000002253 acid Substances 0.000 description 16
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 15
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 15
- 239000011257 shell material Substances 0.000 description 15
- 239000002657 fibrous material Substances 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 230000009471 action Effects 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229920003043 Cellulose fiber Polymers 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000010908 decantation Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 239000003729 cation exchange resin Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 229940032007 methylethyl ketone Drugs 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000000265 homogenisation Methods 0.000 description 4
- -1 hydrogen chloride Chemical class 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 210000000998 shell membrane Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000010420 shell particle Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229920001938 Vegetable gum Polymers 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 238000000498 ball milling Methods 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000013605 boiled eggs Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229940023913 cation exchange resins Drugs 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229940116899 cooked egg shell Drugs 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 125000002228 disulfide group Chemical group 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 238000005213 imbibition Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000000438 stratum basale Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- OGNVQLDIPUXYDH-ZPKKHLQPSA-N (2R,3R,4S)-3-(2-methylpropanoylamino)-4-(4-phenyltriazol-1-yl)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid Chemical compound CC(C)C(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(O)=O)=C[C@@H]1N1N=NC(C=2C=CC=CC=2)=C1 OGNVQLDIPUXYDH-ZPKKHLQPSA-N 0.000 description 1
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241001156002 Anthonomus pomorum Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 102100027522 Baculoviral IAP repeat-containing protein 7 Human genes 0.000 description 1
- 101710177963 Baculoviral IAP repeat-containing protein 7 Proteins 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- ZKPUPHSBFMNFHO-UHFFFAOYSA-N [ClH]1C=CC=C1 Chemical compound [ClH]1C=CC=C1 ZKPUPHSBFMNFHO-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical group OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000010981 drying operation Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 208000010932 epithelial neoplasm Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000994 inner shell membrane Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000754 repressing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000004758 synthetic textile Substances 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/13—Burn treatment
Definitions
- This invention is directed to new and useful methods for stimulating and assisting healing processes in damaged mammalian tissues as, for example, in areas of the human body where tissue has been lost or damaged as a result of injuries such as abrasions, cuts, burns, ulcerations and from surgical procedures and it is also concerned with the preparation of new and useful materials for effectively achieving these objectives.
- a commonly employed procedure is that of viable skin grafting, in which the surgeon transplants shavings of livin epidermal tissue from undamaged areas after suitable preparation.
- Such grafts have varied in size and thickness of the skin shavings used for grafting and in other details of procedure.
- Thicrsch grafts, Ollier- T iersch grafts, Wolfe grafts, pinch grafts, full-thickness and split-thickness grafts, and stamp grafts are names associated with some of the various types of skin grafts and procedures which have been used.
- the surgeon attempts to include portions of the stratum germinativum of the epidermis by cutting across the rete pegs. When such grafts become attached to the surface tissues of the damaged area, they may become vascularized and form islands or centers of epithelialization on the surface of the lesion.
- rafts for which the patient is the donor of the grafted skin are known as autografts.
- the size of the lesion is such that not enough undamaged skin areas remain on the patient to provide autografts to cover the entire surface of the lesion.
- a portion of the lesion may receive an autograft and the remaining damaged area may receive grafts of living skin from another person, or of dead skin from a cadaver.
- grafts known as homografts
- homografts do not persist and do not become finally a part of the skin covering the healed lesion as autografts frequently do, they accomplish many desirable rcsults such as preventing fluid loss, repressing the excessive development of granulation tissue, decreasing pain and stimulating growth of the stratum germinativum of the epidermis at borders of the lesion.
- homograft does not persist and become "ice a part of the skin over the healed lesion it is of great value as a practical measure since, by use of homografts together with autografts, lesions with greater areas and degrees of tissue damage may be satisfactorily treated.
- homografts together with autografts, lesions with greater areas and degrees of tissue damage may be satisfactorily treated.
- the limited availability of human skin in relation to the needs for homografts makes it important that other more readily available materials, capable of performing one or more of the functions of the homegraft, be found and that practical procedures for their preparation and use should be developed.
- egg-shell membrane can be treated in such a manner to convert it into such forms as to make its use highly pacticable and of great value in meeting problems encountered in connection with successful clinical management of skin-denuded areas, deep-tissue wounds and lesions which are refractory to the usual treatment procedures. Tlese have heretofore frequently required the utilization of autograft and to a lesser extent, and with sea success, the use of homografts.
- the present invention makes possible the production of novel egg-Shel membrane products, which are highly eifcctive for use in place of human skin in skin grafting operations, which are easily manipulated in use and which can be made by simple practical procedures.
- novel egg-shell membrane products in accordance with the present invention, depending on the type and condition of the lesion to which they may be applied, they frequently display additional desirable properties such as a strong emostatic action which tends to arrest bleeding, and a soothing, pain-relieving action, a type of action which some work..- ers have reported to be a conspicuous property of homografts of human skin.
- novel eg -shell membrane products are produced, in accordance with the present invention, they are readily and effectively storable so that they can be stockpiled in any desired amounts to meet emergency clinical situations which might be created due to holocausts, such as extended fires, Wars and the like.
- These products constitute an eifective treatment procedure providing a number of desirable characteristics and properties only some of which have heretofore been obtained by grafts of human skin.
- novel egg-shell membrane products made in accordance with the present invention play exceedingly important roles in tissue healing and grafting procedures. They serve, in fact, as ettective biological dressings. In addition, by reason of their stimulating the regeneration of epithelial tissues and by providing topically certain factors which are essential aids in the natural processes of tissue repair, they appear actively to promote the regeneration of tissues by stimulation and possibly by providing essential components for synthesis of the protein of the regenerated tissues.
- the present invention in broad terms, involves the production and utilization or treatment of separated particles, mainly non-fibrous in form, prepared or derived from egg-shell membrane.
- separated particles mainly non-fibrous in form
- egg-shell membrane Various etfective procedures by which such may be accomplished are described in detail below.
- egga shell membrane is washed and dried and then ball milled to convert it into a pulverulent or powder product which is essentially non-fibrous in form.
- essentially nonfibrous products may consist solely of egg-shell membrane material or they may consist of mixtures of the egg-shell membrane material with various other materials.
- the eggshell membrane essentially non-fibrous product may, for example, be admixed with fibrous maerials such as cotton or cellulosic fibers and deposited as a coating or coatings on certain desirable base materials as, for instance, cellulose or alpha-cellulose or regenerat d cellulose or cellulose acetate or nylon or similar natural or synthetic textile fabric or plastic base materials, woven or non-woven, in sheet form, perforated or imperforate, and, if desired, the egg-shell membrane non-fibrou product may be applied to either one or both sides of the base materials.
- fibrous maerials such as cotton or cellulosic fibers
- fibrous maerials such as cotton or cellulosic fibers
- deposited as a coating or coatings on certain desirable base materials as, for instance, cellulose or alpha-cellulose or regenerat d cellulose or cellulose acetate or nylon or similar natural or synthetic textile fabric or plastic base materials, woven or non-woven, in sheet form, perforated or imper
- the egg-shell membrane essentially non-fibrous materials may be bonded to the base material through suitable adhesive compositions such as compositions containing pectin, gelatin, starch and starch derivatives, innocuous vegetable gums, or like innocuous adhesive materials, Typical of such felts or sheets are those made from mixtures, in varying proportions, of uncooked or cooked egg-shell membrane essentially non-fibrous ma:
- said egg-shell membrane material may be directly used, inthe practice of my invention, in its particulate solid form which provides large surface area per unit of weight.
- the egg-shell membrane essentially non-fibrous materials are mixed with other materials, for example, cellulosic materials such as alpha cellulose in fiber form, such latter materials should advantageously amount to not more than 75%, and, better still, not greater than 50%, ofthe vdry weight of the total of said material and said egg-shell membrane essentially non-fibrous material.
- the cellulosic or like fibers or other materials may be admixed with the eg shell membrane essentially non-fibrous material inaqueous suspension and the resulting fiber pulp mixture may then be laid down to form the felted sheet, or a coating or layer on a woven or non-woven base.
- a preliminary felted sheet may be 'laid down from a cellulosic or other fiber pulp and the essentially nonfibrous egg-shell membrane material deposited thereon or embedded in, or intimately mingled therein.
- mixtures can be made where the egg-shell membrane essentially non-fibrous materials are admixed with other particulate solids to producefinal products in the form of pulverulent or powdered products having low bulk densities.
- the new and useful egg-shell membrane products contemplated by the present invention encompass dry particulate materials having a low bulk density, generally in the range of 0.05 to 0.40 grams per cubic centimeter, depending upon the particular manner of preparation, and a very large area of surface for a given weight of material, all as hereafter described in detail.
- dry particulate materials having a low bulk density, generally in the range of 0.05 to 0.40 grams per cubic centimeter, depending upon the particular manner of preparation, and a very large area of surface for a given weight of material, all as hereafter described in detail.
- they are either essentially non-fibrous in character or, if they do encompass, include or compirse particles of a fibrous character, the nature or sizes or shapes or proportions of the fibers are such that said membraneproducts are incapable of being laid down, without the addition of other fiber materials, to form dried felts or sheets which are formsustaining and which can be handled.
- the egg-shell membrane products here contemplated may, however, as indicated, produce form-sustaining dried felts or sheets which can be handled reasonably without crumbling or disintegrating only if they are admixed with a sufficient quantity of fiber materials of a character such as in themselves, without, the additionof the egg-shell membrane products, are capable of producing such latter felts orsheets utilizing techniques such as are known in the art for the production of felts or sheets from'fiber pulps.
- nonfibrous as applied to the egg-shell membrane products of the present invention, will, accordingly, be understood to mean. products such as have been characterized in this paragraph and wherein the form or shape of the particles, as distinguished from the internal structure of the particles, are non-fibrous.
- egg-shell membrane is desirably washed and dried and then reduced to exceedingly small mainly non-fibrous particles.
- a homogenizer such as a Vir Tis or theplike, the cutting blades of which can be caused to rotate up, to a speed of approximately 45,000 rpm.
- Other types of equipment can, however, be used.
- the usual Waring blendors and the Osterizers employed in the home for preparing dispersions and for disintegration and emulsification of food products have been found to give satisfactory results, especially if the rotating blades are first sharpened.
- dried egg-shell membranes may be converted into finely divided particles having mainly a non-fibrous form by ball-milling the dried egg-shell membranes; or the dried egg-shell membrane may be finely subdivided into particles having mainly non-fibrous form by subjecting the dried egg-shell membranes to the action of a high speed homogenizer while the membrane pieces are suspended in air or in other suitable gases, or in a liquid which does not soften, or does not appreciably soften, the dried egg-shell membrane as a result of imbibition of the liquid by the dried egg-shell membrane.
- liquids examples include cyclohexanol, aniline, N-Ndimethyl formamide, water-free methyl-ethyl ketone (Z-butanone), 1:4-dioxane, benzthiazol, and pyridine.
- Z-butanone methyl-ethyl ketone
- 1:4-dioxane benzthiazol
- pyridine aqueous liquids which are not imbibed by dried eggshell membrane can be used, those above mentioned being simply illustrative.
- the finely divided mainly non-fibrous particles can be readily separated from the suspending liquid employed. This step is accomplished by filtration, by centrifugation, by evaporation of the suspending liquid or by other well-known procedures for separating solids from liquids.
- the adhering residue of suspending liquid, if any, is then removed from the egg-shell membrane particles by washing the particles with suitable solvents and these latter are removed by filtration, centritugation, evaporation or other convenient means. Care must be taken not to squeeze or compress the disintegrated or homogenized membrane mass as this tends to cause the formation of hard aggregates on drying.
- the resulting dry solid material consists of aggregates o; S'lltlll particles of disintegrated egg-shell membrane.
- the dry aggregates of the mainly non-fibrous particles are easily disaggregated into separated mainly non-fibrous particles by acting on the above described aggregates in the homogenizer in the absence of any suspending liquid, the aggregate pieces being disaggregated in air, or in other suitable gases, by high speed action of the homogenizer.
- the dry, pulverulent mass of separated air-dispersed or gas-dispersed mainly non-fibrous particles is now removed from the homogenizer.
- the disaggregation of the dry mainly non-fibrous aggregates in the homogenizer or other suitable high speed disintegrator requires but a short period of action at high speeds. Prolonged subjection of the products to treatment in the disaggregating apparatus at high speeds may build up elevated temperatures in the product which could damage it.
- the mainly non-fibrous disaggregated disintegrated eggshell membrane substance may be used for the therapeutic purposes previously described.
- the above described mainly non-fibrous disintegrated disaggregated egg-shell membrane may be applied as a coating to cotton gauze, to paper, to woven and to non-Woven fabrics, to plastic sheets both perforated and imperforate, or to other desirable base materials, on one or both sides, and the eggshell membrane products may be made to adhere, if desired, to the surface of the base materials by means of suitable adhesive compositions, such as compositions containing pectin, gelatin, starch and/or starch derivatives, vegetable gums or soluble synthetic resinous polymeric substances and like innocuous adhesive materials.
- suitable adhesive compositions such as compositions containing pectin, gelatin, starch and/or starch derivatives, vegetable gums or soluble synthetic resinous polymeric substances and like innocuous adhesive materials.
- the egg-shell membranes which constitute the starting material used in carrying out my invention can be separated from egg shells in any convenient manner.
- this may be accomplished in a purely mechanical manner as, for instance, by rolling and pulling the membranes away from the Washed egg shells after removal of the yoke and albumen of fresh or uncooked eggs.
- cooked egg-shell membranes these, too, may be removed by pulling them away from washed egg-shells which have been placed, for example, in boiling water to effect such cooking.
- it is desirable to effect the separation of the egg-shell membranes from the egg-shells by grasping an edge of the membranes and rolling or pulling them away from the calcareous part of the egg shells.
- a combination of chemical and mechanical means can be utilized.
- One convenient procedure is to agitate, in a churn or the like, water-washed, very coarsely chopped or shredded egg shells containing the adhering membranes with several times their weight of a dilute acid, for instance, a 0.25 to 4% solution in water of mineral acids such as hydrogen chloride, or a 2 to 15% solution in water of organic acids such as formic acid, or acetic acid or lactic acid or propionic acid, for a period of time, generally one to several hours, agitating until the membranes are loosened and fall away from the egg shell particles.
- a dilute acid for instance, a 0.25 to 4% solution in water of mineral acids such as hydrogen chloride, or a 2 to 15% solution in water of organic acids such as formic acid, or acetic acid or lactic acid or propionic acid
- the membranes may then be separated from the egg shell pieces by counter-current washing with water or aqueous solutions and by decantation steps. In case a small proportion of shell particles still remains attached to some membrane pieces, the membrane pieces are collected, washed with water by counter-current procedures and drained, then agitated for a period of one to four hours with a small amount of the dilute acid solution, followed by separation of the acid solution and counter-current washing of the membranes with decantation from bits of sedimented shell, using several changes of water.
- the separation of the membrane from the shell may be effected with carbonic acid, that is, with an aqueous solution of carbon dioxide under pressure, though the process is time consuming.
- the time needed in this process may be decreased by agitating the shell pieces and by including with the shell material a cation exchange resin, for example, a cross-linked polystyrene polysulr'onic acid, in the free acidic or hydrogen form, while the shell pieces are mixed with a solution of carbon dioxide in water, under compressed carbon dioxide.
- the separated membranes are finally washed with water or aqueous solutions using countercurrent washing and decantation steps and the undissolved shell pieces and the cation exchange resin particles are separated with suitable sieves.
- the resin can then be regenerated to the free acid or hydrogen form by mineral acids, preferably hydrochloric acid, and is then ready for re-use.
- the separated spent organic acid solutions may be regenerated for re-use conveniently by passing them through a column of appropriate cation exchange resin in acidic or hydrogen form and the cation exchange resins themselves may be regenerated to their acid forms with mineral acid solutions, such as dilute hydrochloric acid.
- mineral acid solutions such as dilute hydrochloric acid.
- the vessel is then opened and the contents placed in a jar and agitated, any gases evolved being allowed to escape.
- the membranes which separated from the egg shells are removed by decantation. Repeated washing with water is followed by decantations between washings which result in effecting removal or" substantially all of the membranes from the egg shells and in removing all of the shell particles from the membranes.
- the egg-shell membranes after removal from t e egg shells, are desirably washed in water or in aqueous media. For convenience in storage or subsequent handling, it is desirable to subject them to a partial or complete drying operation depending on the physical form of the product desired from the subsequent homogenization or disintegration step. If the membranes are to be disintegrated, homogenized or pulped, for example, in a non-aqueous medium for the production of mainly non-fibrous eggshell membrane particles, a partial removal of the water contained in the washed membranes may be accomplished simply by pressing the drained membranes between absorbent surfaces, for instance bibulous paper such as blotting paper.
- the blotter dry eggshell membranes contain about 30% by weight of membrane material, the balance being water, and they may be stored under refrigerated or freezing conditions for subsequent use in accordance with the teachings of my invention.
- the drained membranes may be dried in air or in a vacuum drier and such dried membranes may be stored for prolonged periods, indeed almost indefinitely, at room temperatures without deterioration. They may be used in this form in the subsequent disintegration or homogenization step.
- Example 1 10 grams of blotter-dry mechanically separated eggshell membranes (equal to about 3 grams dried membrane) which prior to blottendrying are previously washed with water, are cut up into thin strips about 7 to A inch wide and /4 to inch long and air-dried, then placed into a laboratory ball mill containing alundum balls and ball milled until an essentially non-fibrous powder product results. Its bulk density is 0.31 gram percubic centimeter.
- Example 2 A11 alpha cellulose fiber aqueous suspension prepared by homogenizing 1 gram of filter paper in 175 ml. water is poured onto a stainless steel screen box having 200 open ings to the lineal inch and the water is allowed to drain therethrough. The resulting felted mass of cellulose fibers is then sucked'down with suction and 1.2 grams of the egg-shell membrane product produced pursuant to Example 1, suspended in 175 ml. water, is poured over the surface of the felted mass of cellulose fibers. The suction is stopped and then it) ml. or" a it.% w.'/v.
- Example 1 roduct produced pursuant to.
- Example 1 may be :ed together before pouring the mixture on the screen This results in a sheet with both sides essentially similar and with the egg-shell membrane product distributed through the sheet.
- humectant so as to inhibit undue embrittlementent or drying out of the felts or sheets of th felted fibers containing said egg-shell membrane product.
- otl er humectants generally aliphatic polyols, can be used, typical of which are sorbitol and propylene glycol.
- the humectant can be incorporated at any suitable stage of the process.
- Example 3 1 1e separated from the egg shells by the acetic acid pressure procedure described above.
- the product is a light fluffy p -ticulate material which has an apparent bulk density of 9.555 gram per cubic centimeter.
- the product consists mainly of pieces of egg-shell membrane and particles of egg-shell membrane but also contains numerous individual free fibers as well as a few matted agglomerates of these freed fibers.
- the particles are much larger than the particles obtainable by ball milling the same lrind of starting material.
- the freed and agglomerated fibers constitute perhaps 5% to 10% of the total product.
- Example 5 1.25 grams of air-dried, very coarsely shredded or sliced pieces of uncooked egg-shell membrane are placed in the 250 ml. flash of the Vir Tis and 170ml. of 'anhydrous methyl-ethyl ltetone (Z-butanone) are added. There is no apparent softening of the crisp membrane pieces indicating little if any imb-ibition of the liquid into thev structural elements of the membrane. The Vir Tis machine is operated at gradually increasing speeds and finally for 12 minutes at 4100i) rpm. while the flash is cooled with an ice-water bath. The pieces of membrane rapidly disintegrate and in 12 minutes the agitated liquid looks like milk.
- 'anhydrous methyl-ethyl ltetone Z-butanone
- the product may also be filtered off from the methylethyl ketone and added to a water suspension of 1.0 gram of alpha-cellulose fiber pulp. The mixture may then be shaken to obtain even distribution and poured into the previously levelled screen box used for making sheets.
- a good serviceable sheet consisting of a mixture of alphacellulose and egg-shell membrane is readily formed in this manner, having an area of 16 square inches.
- the suspending liquid may be conveniently removed by subjecting the suspension of egg-shell membrane mainly non-fibrous material to commercial drying, particularly spray-drying procedures, such as are used for the recovery of heat labile solids from aqueous and other suspensions or solutions.
- the dry egg-shell membrane fiber aggregates resulting from the spray-drying operation may then be converted to an extremely light pulverulen-t product by subjecting these aggregates to the previously described disaggregat-ive procedure for the preparation of the extremely light pulverulent product.
- the following table shows the results of several experiments on egg-shell membrane disintegration utilizing various organic suspending liquids in the homogenizer.
- the coarsely chopped membranes in the suspending liquid were subjected to the action of the homogenizer operating at a speed of 45,000 r.p.m.
- Homogenization was carried out in the small receptacle using 80 ml. of liquid and the indicated quantity of air-dried membrane.
- the temperature was controlled by a water bath or by an ice bath around the receptacle and the contents of the receptacle were thus kept from temperatures above 50 C.
- Anhydrous 0.75 3.5 Product consisted mainly of Pyridine; not small particles; a few fiber imbibed. pieces were seen, frequently stuck together. Some bits or pieces of membrane seen of size in microns: Large 25 x 19, SmalllG x 13. Fiber pieces 6 x 16 when moist.
- Chlorol'crm, 0.75 6 Product essentially a pows t der. Small particles were i bi d, 12 x 12 microns or less and numerous. Average partiole 14 x 14 microns. Largest bit 120 x 84 microns. A few fibers were seen; longest 132 microns, others 12 to 36 microns long.
- the egg-shell membrane products obtained from experiments 1, 2 and 3 in the foregoing table can be effectively utilized in the preparation of the powder form or" egg-shell membrane products in the manner described above.
- the egg-shell membrane products shown in experiments 1, 2 and 3 in the foregoing table can be filtered off, washed with aceto .e to remove suspending liquid,
- the dried egg-shell membrane particulate mainly non-fibrous materials of my invention are used to assist the healing of denuded areas on the human body is dependent, in part, on the nature of such areas.
- a felted sheet containing the egg-shell membrane material in essentially non-fibrous form, or particulate eg -shell membrane product in essentially nondibrous form described above is simply placed over said area to cover same. To this end the sheet may be cut to conform in contour to that of the area to be covered.
- a protective cover of hospital gauze or the like may be laid gently and preferably relatively loosely over the sheet to protect the treated lesion and to prevent contamination.
- the area is desirably packed with the dried egg-shell membrane mainly non-fibrous material.
- the 100% egg-shell membrane mainly non-fibrous material can be packed or lightly tamped into the area throughout its depth.
- the area is again protected from contamination by hospital gauze as described above.
- additional amounts of the dried egg-shell membrane mainly non-fibrous materials may be applied to the denuded area as may be indicated by the rate and degree of healing.
- the felted fiber fabrics or sheets containing the eggshell membrane material in essentially non-fibrous form, and the egg-shell membrane powder or non-fibrous par ticulate products produced in accordance with my present invention function, when utilized in the manner described above, as protective barriers for the denuded areas, exercising a mechanical protective action as well as markedly assisting in the healing of the lesion.
- the body fluids present in the tissues of the lesion may become intimately admixed with the particles of the egg-shell membrane mainly non-fibrous products and on drying form a reinforced crust having considerable mechanical protective strength.
- the enzymic substances present in such body fluids and tissue exudates may act on the said egg-shell membrane particles, presenting as they do an extensive surface area for enzyme adsorption, and such enzymic action may result in the formation of substances which facilitate the healing process and/or stimulate the growth of repair tissues and ultimately of new skin covering.
- the dried egg-shell membrane mainly non-fibrous products produced pursuant to my invention are characterized by exceptionally great surface area per unit of weight. This fact appears to play some role in relation to the manner in which said materials of my invention function in assisting the healing processes here involved, with due regard for the fact that the exact mechanism of the actions concerned in such processes is presently unknown.
- an epithelioma was treated with X- rays and the resulting lesion, on the forehead of a woman, was treated by the application thereto of particulate dried uncooked egg-shell membrane product such as produced pursuant to Example 1 hereof.
- the lesion had a diameter of about 1 inch.
- Said lesion, under said treatment, was found to be completely crusted over at the end of one week, and healing of the area was complete in two weeks. Standard techniques usually require healing periods of six to seven weeks as this type of lesion is known to be very slow to heal.
- aqueous suspensions of the egg-shell membrane mainly non-fibrous products prepared as described above may be treated in aqueous media with enzymes, preferably purified, of proteolytic character, such as papain, ficin, pepsin, trypsin and trypsin related enzymes, bromelin and other proteolytic enzymes of vegetable and/ or of animal origin so as to bring about partial digestion of the egg-shell membrane material.
- enzymes preferably purified, of proteolytic character, such as papain, ficin, pepsin, trypsin and trypsin related enzymes, bromelin and other proteolytic enzymes of vegetable and/ or of animal origin so as to bring about partial digestion of the egg-shell membrane material.
- the finished products may contain active proteolytic enzymes which serve, in certain instances, to enhance the utility of the egg-shell membrane digest product.
- Useful products can also be prepared from the eg shell membrane mainly non-fibrous products herein described by oxidation and also by reduction techniques whereby to modify the disulfide linkages present in the eggshell membrane substance.
- Oxidations have been carried out with hydrogen peroxide, urea peroxide, perscetic acid and pertorrnic aciclto oxidize disulfide groups, presen in eggshell membrane materials, to intermediate states of oxidation of the disulfide linkages and to form cysteic acid groups.
- Such latter acidic groups can be reacted chemically for instance with basic amino acids such as lysine, arginine, histidine, and with methionin as well as with basic peptides.
- the dried egg-shell membrane mainly non-fibrous products can be sterlized, preferably prior to final packaging. This may be accomplished by techniques known in the art as, for example, by treatment with gaseous ethyl ne oxide or propylene oxide, or mixtures of each or" these gases with other gases such as mixtures of ethylene oxide gas with carbon dioxide gas, preferably under pressure and at slightly elevated temperatures, for example at 40 C. to 75 C., and at pressures of 2 to 6 atmospheres for a period of 2 to 4 hours. Sterilization may also be carried out using beta propiolactone or, in certain cases, with moist or dry heat. However, depending upon the exact manner in which the aforesaid egg-shell membrane products have been prepared and handled, they may have a practical degree of'sterility without the necessity for any special sterilizing treatments.
- said dried materials may be impregnated with the desired enzyme, drug, antibiotic or bacteriostatic substance or mixtures of these either'by mechanical admixing of the said egg-shell membrance products with the drug in dry form or the drug may be dissolved in a suitable slovent and the drug solution applied to the egg-shell membrane products at convenient points in the preparation of the eggshell membrane products herein escribes or to the finished products themselves.
- antibiotics are neomycin bacitracin, and particularly, broad spectrum antibiotics such as chlortetracycline, tetracycline, oxytetracycline, chloramphenicol, sulfa drugs and others.
- While my invention is especially applicable to the 'reatment of egg-shellmembranesobtained from chicken eggs, it is also useful in relation to egg-shell membranes obtained from eggs of other birds and fowl as, for instance, duck eggs.
- egg-shell membranes prepared from the eggs of chickens because these represent the most available sources of large supplies. of egg-shell membranes.
- a dry felt fiber sheet containing a finely divided egg-shell 'membrane powder in essentially non-fibrous form As an article of manufacture for assisting the healing of skin-denuded areas on the body, a dry felt fiber sheet containing a finely divided egg-shell 'membrane powder in essentially non-fibrous form.
- a dry sheet comprising a layer of fiberfelt material carrying finely divided eg -shell membrane powder in essentially non-fibrous form on a fabric base member.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
United States Patent 3,194,732 ASSESTENG HEALHNG 9F SKllN-DENUDED AREAS @N THE BGDY WITH DRHED NON-FIBRUUS EGGSHELL MEMBRANE PRQDUCTS AND CGMPUSITIGNS THEKEFUR Irene Neuhauser, 5759 S. Kenwood, @hicago 37, Ill. No Drawing. Filed 0st. 3, 1960, Ser. No. 59,804 Claims. (Cl. 167-53) This application is a continuation-in-part of my application Serial No. 845,104, filed October 8, 1959, now abandoned.
This invention is directed to new and useful methods for stimulating and assisting healing processes in damaged mammalian tissues as, for example, in areas of the human body where tissue has been lost or damaged as a result of injuries such as abrasions, cuts, burns, ulcerations and from surgical procedures and it is also concerned with the preparation of new and useful materials for effectively achieving these objectives.
Numerous approaches have heretofore been made and much study has been directed to problems involved in bringing about healing of areas where skin has been wholly or partially lost and where underlying tissues may have been damaged or removed as a result of burns, cuts, abrasions, ulcerations or from surgical intervention. The nature and character of the treatments currently used vary with techniques and preferences of individual surgeons and dependent, also, on the nature, surface conditions and extent and depth of tissue involvement.
A commonly employed procedure is that of viable skin grafting, in which the surgeon transplants shavings of livin epidermal tissue from undamaged areas after suitable preparation. Such grafts have varied in size and thickness of the skin shavings used for grafting and in other details of procedure. Thicrsch grafts, Ollier- T iersch grafts, Wolfe grafts, pinch grafts, full-thickness and split-thickness grafts, and stamp grafts, are names associated with some of the various types of skin grafts and procedures which have been used. In preparing skin shavings for grafts, the surgeon attempts to include portions of the stratum germinativum of the epidermis by cutting across the rete pegs. When such grafts become attached to the surface tissues of the damaged area, they may become vascularized and form islands or centers of epithelialization on the surface of the lesion.
rafts for which the patient is the donor of the grafted skin are known as autografts.
It frequently happens that the size of the lesion is such that not enough undamaged skin areas remain on the patient to provide autografts to cover the entire surface of the lesion. In such cases a portion of the lesion may receive an autograft and the remaining damaged area may receive grafts of living skin from another person, or of dead skin from a cadaver. Although such grafts, known as homografts, do not persist and do not become finally a part of the skin covering the healed lesion as autografts frequently do, they accomplish many desirable rcsults such as preventing fluid loss, repressing the excessive development of granulation tissue, decreasing pain and stimulating growth of the stratum germinativum of the epidermis at borders of the lesion. Eventually homografts are rejected, that is, they slough off. it may be possible by then to cut additional skin grafts from the now-heated donor sites and so eventually to cover the lesion completely with viable autografts. Considerable effort has been directed to bring about the permanent survival of viable homografts but only slight progress has been achieved and no clinical applications of any of these studies have been widely accepted.
Although the homograft does not persist and become "ice a part of the skin over the healed lesion it is of great value as a practical measure since, by use of homografts together with autografts, lesions with greater areas and degrees of tissue damage may be satisfactorily treated. However, the limited availability of human skin in relation to the needs for homografts makes it important that other more readily available materials, capable of performing one or more of the functions of the homegraft, be found and that practical procedures for their preparation and use should be developed.
An area of approach which has been extensively studied, extending back approximately eighty years, has involved the utilization of eggshell membranes, the membrana testacea of eggs of domestic fowl. Numerous workers have utilized egg-shell membrane as a substitute for skin grafts but with varying degrees of success. in certain cases, Where fresh egg-shell membrane was used in the repair of ruptured ear drums and as a graft to damaged areas from which skin had been entirely or partially lost, it was stated to have achieved reasonable success. In some cases, reported by other workers, fresh eggshell membrane was found to be inefiective. Certain physiologists and surgeons concluded that satisfactory results could be obtained provided (1) that the eggshell membrane pieces were applied with that surface towards the surface of the lesion which was previously in contact with the egg shell, and not the reverse, and (2) that the area was scarified until bleeding was produced prior to the application thereto of the egg-shell membrane. Unless these rules were carefully observed, according to certain of the workers in the art, tie egg shell membrane would not become attached organically to the denuded area to which it was applied. Anotherimportant criterion for the proper utilization of egg-shell membrane, according to early workers in the art, was to insure that, when applied with the shell-side to the lesion, it be in contact with the proliferating cells of the stratum germinativurn of the skin at the periphery of the lesion. The said workers reported that the eggshell membrane itself, and of its own initiative, takes no part in the formation of connective tissue but that the eggshell membrane substance is transformed into connective tissue gradually, there being an interpenetration of the proliferating tissue into the structure of the membrane, followed by the establishment of circulation to care for the newly formed connective tissue structures.
Other workers have insisted that eggshell membrane be applied with the albumen side toward the lesion, an exact reversal of the opinion of the above mentioned workers. The basis for this was the'belief that the inner side of the inner shell membrane contained nucleated cells which served as feel for the healing processes. It is now known that such nucleated cells do not exist in egg-shell membranes. Still other workers employed the shell membranes from boiled eggs but disregarded the question of which side was placed in contact with the lesion.
Despite repeated investigation of the possible use of egg-shell membrane as a substitute for skin in grafting, the practice has not come into any appreciable or significant use. The dil'ficulties of separating egg-shell membrane from eggs, the diiiicult problems of handling moist membrane pieces and the indifferent success which has attended the use of egg-shell membrane as well as other factors, have all combined to make such approaches of dubious practical value.
In accordance with the present invention, highly important and significant improvements have been made which render the use of egg-shell membrane of great practical importance. It has been found, among other things, in accordance with the present invention, that egg-shell membrane can be treated in such a manner to convert it into such forms as to make its use highly pacticable and of great value in meeting problems encountered in connection with successful clinical management of skin-denuded areas, deep-tissue wounds and lesions which are refractory to the usual treatment procedures. Tlese have heretofore frequently required the utilization of autograft and to a lesser extent, and with sea success, the use of homografts. The present invention makes possible the production of novel egg-Shel membrane products, which are highly eifcctive for use in place of human skin in skin grafting operations, which are easily manipulated in use and which can be made by simple practical procedures. Moreover, in the various forms in which the novel egg-shell membrane products are produced, in accordance with the present invention, depending on the type and condition of the lesion to which they may be applied, they frequently display additional desirable properties such as a strong emostatic action which tends to arrest bleeding, and a soothing, pain-relieving action, a type of action which some work..- ers have reported to be a conspicuous property of homografts of human skin. Moreover, in the various forms in which the novel eg -shell membrane products are produced, in accordance with the present invention, they are readily and effectively storable so that they can be stockpiled in any desired amounts to meet emergency clinical situations which might be created due to holocausts, such as extended fires, Wars and the like. These products constitute an eifective treatment procedure providing a number of desirable characteristics and properties only some of which have heretofore been obtained by grafts of human skin.
The novel egg-shell membrane products made in accordance with the present invention play exceedingly important roles in tissue healing and grafting procedures. They serve, in fact, as ettective biological dressings. In addition, by reason of their stimulating the regeneration of epithelial tissues and by providing topically certain factors which are essential aids in the natural processes of tissue repair, they appear actively to promote the regeneration of tissues by stimulation and possibly by providing essential components for synthesis of the protein of the regenerated tissues.
The present invention, in broad terms, involves the production and utilization or treatment of separated particles, mainly non-fibrous in form, prepared or derived from egg-shell membrane. Various etfective procedures by which such may be accomplished are described in detail below.
Pursuant to one aspect of the present invention, egga shell membrane is washed and dried and then ball milled to convert it into a pulverulent or powder product which is essentially non-fibrous in form. These essentially nonfibrous products may consist solely of egg-shell membrane material or they may consist of mixtures of the egg-shell membrane material with various other materials. The eggshell membrane essentially non-fibrous product may, for example, be admixed with fibrous maerials such as cotton or cellulosic fibers and deposited as a coating or coatings on certain desirable base materials as, for instance, cellulose or alpha-cellulose or regenerat d cellulose or cellulose acetate or nylon or similar natural or synthetic textile fabric or plastic base materials, woven or non-woven, in sheet form, perforated or imperforate, and, if desired, the egg-shell membrane non-fibrou product may be applied to either one or both sides of the base materials. Furthermore, if desired, the egg-shell membrane essentially non-fibrous materials may be bonded to the base material through suitable adhesive compositions such as compositions containing pectin, gelatin, starch and starch derivatives, innocuous vegetable gums, or like innocuous adhesive materials, Typical of such felts or sheets are those made from mixtures, in varying proportions, of uncooked or cooked egg-shell membrane essentially non-fibrous ma:
terial with cellulosic fibers,.ror instance, 35% to 65% alpha cellulose fibers, balance said egg-shell membrane essentially non-fibrous material.
In another, and particularly preferred, aspect of my invention, instead of converting the egg-shellmembrane essentially non-fibrous material into dry felt or sheet form, as indicated above, said egg-shell membrane material may be directly used, inthe practice of my invention, in its particulate solid form which provides large surface area per unit of weight.
In those instances where the egg-shell membrane essentially non-fibrous materials are mixed with other materials, for example, cellulosic materials such as alpha cellulose in fiber form, such latter materials should advantageously amount to not more than 75%, and, better still, not greater than 50%, ofthe vdry weight of the total of said material and said egg-shell membrane essentially non-fibrous material. The cellulosic or like fibers or other materials may be admixed with the eg shell membrane essentially non-fibrous material inaqueous suspension and the resulting fiber pulp mixture may then be laid down to form the felted sheet, or a coating or layer on a woven or non-woven base. Alternatively, a preliminary felted sheet may be 'laid down from a cellulosic or other fiber pulp and the essentially nonfibrous egg-shell membrane material deposited thereon or embedded in, or intimately mingled therein. Analogously, mixtures can be made where the egg-shell membrane essentially non-fibrous materials are admixed with other particulate solids to producefinal products in the form of pulverulent or powdered products having low bulk densities.
The new and useful egg-shell membrane products contemplated by the present invention encompass dry particulate materials having a low bulk density, generally in the range of 0.05 to 0.40 grams per cubic centimeter, depending upon the particular manner of preparation, and a very large area of surface for a given weight of material, all as hereafter described in detail. In the form inwhich they are used, they are either essentially non-fibrous in character or, if they do encompass, include or compirse particles of a fibrous character, the nature or sizes or shapes or proportions of the fibers are such that said membraneproducts are incapable of being laid down, without the addition of other fiber materials, to form dried felts or sheets which are formsustaining and which can be handled. reasonably without crumbling or disintegratin The egg-shell membrane products here contemplatedmay, however, as indicated, produce form-sustaining dried felts or sheets which can be handled reasonably without crumbling or disintegrating only if they are admixed with a sufficient quantity of fiber materials of a character such as in themselves, without, the additionof the egg-shell membrane products, are capable of producing such latter felts orsheets utilizing techniques such as are known in the art for the production of felts or sheets from'fiber pulps. The term nonfibrous, as applied to the egg-shell membrane products of the present invention, will, accordingly, be understood to mean. products such as have been characterized in this paragraph and wherein the form or shape of the particles, as distinguished from the internal structure of the particles, are non-fibrous.
Inthe practice of the present invention, egg-shell membrane is desirably washed and dried and then reduced to exceedingly small mainly non-fibrous particles. This is conveniently and very advantageously done in a high speed homogenizing apparatus. 1 have found that ex cellent results are obtained with a homogenizer such as a Vir Tis or theplike, the cutting blades of which can be caused to rotate up, to a speed of approximately 45,000 rpm. Other types of equipment can, however, be used. The usual Waring blendors and the Osterizers employed in the home for preparing dispersions and for disintegration and emulsification of food products have been found to give satisfactory results, especially if the rotating blades are first sharpened. Any other type of equipment may be employed so long as it and the details of procedure used serve to convert the egg-shell membrane into finely divided mainly non-fibrous form. For example, dried egg-shell membranes may be converted into finely divided particles having mainly a non-fibrous form by ball-milling the dried egg-shell membranes; or the dried egg-shell membrane may be finely subdivided into particles having mainly non-fibrous form by subjecting the dried egg-shell membranes to the action of a high speed homogenizer while the membrane pieces are suspended in air or in other suitable gases, or in a liquid which does not soften, or does not appreciably soften, the dried egg-shell membrane as a result of imbibition of the liquid by the dried egg-shell membrane. Examples of such liquids are cyclohexanol, aniline, N-Ndimethyl formamide, water-free methyl-ethyl ketone (Z-butanone), 1:4-dioxane, benzthiazol, and pyridine. Numerous other nonaqueous liquids which are not imbibed by dried eggshell membrane can be used, those above mentioned being simply illustrative.
After homogenization or disintegration of the egg-shell membrane, the finely divided mainly non-fibrous particles can be readily separated from the suspending liquid employed. This step is accomplished by filtration, by centrifugation, by evaporation of the suspending liquid or by other well-known procedures for separating solids from liquids. The adhering residue of suspending liquid, if any, is then removed from the egg-shell membrane particles by washing the particles with suitable solvents and these latter are removed by filtration, centritugation, evaporation or other convenient means. Care must be taken not to squeeze or compress the disintegrated or homogenized membrane mass as this tends to cause the formation of hard aggregates on drying. The resulting dry solid material consists of aggregates o; S'lltlll particles of disintegrated egg-shell membrane. The dry aggregates of the mainly non-fibrous particles are easily disaggregated into separated mainly non-fibrous particles by acting on the above described aggregates in the homogenizer in the absence of any suspending liquid, the aggregate pieces being disaggregated in air, or in other suitable gases, by high speed action of the homogenizer. The dry, pulverulent mass of separated air-dispersed or gas-dispersed mainly non-fibrous particles is now removed from the homogenizer. The disaggregation of the dry mainly non-fibrous aggregates in the homogenizer or other suitable high speed disintegrator requires but a short period of action at high speeds. Prolonged subjection of the products to treatment in the disaggregating apparatus at high speeds may build up elevated temperatures in the product which could damage it.
Pursuant to one embodiment of the present invention, the mainly non-fibrous disaggregated disintegrated eggshell membrane substance may be used for the therapeutic purposes previously described.
Pursuant to another embodiment of my invention, the above described mainly non-fibrous disintegrated disaggregated egg-shell membrane, as previously described, may be applied as a coating to cotton gauze, to paper, to woven and to non-Woven fabrics, to plastic sheets both perforated and imperforate, or to other desirable base materials, on one or both sides, and the eggshell membrane products may be made to adhere, if desired, to the surface of the base materials by means of suitable adhesive compositions, such as compositions containing pectin, gelatin, starch and/or starch derivatives, vegetable gums or soluble synthetic resinous polymeric substances and like innocuous adhesive materials.
The egg-shell membranes which constitute the starting material used in carrying out my invention can be separated from egg shells in any convenient manner. Thus, for example, this may be accomplished in a purely mechanical manner as, for instance, by rolling and pulling the membranes away from the Washed egg shells after removal of the yoke and albumen of fresh or uncooked eggs. In the case of cooked egg-shell membranes, these, too, may be removed by pulling them away from washed egg-shells which have been placed, for example, in boiling water to effect such cooking. In either case it is desirable to effect the separation of the egg-shell membranes from the egg-shells by grasping an edge of the membranes and rolling or pulling them away from the calcareous part of the egg shells.
Instead of employing purely mechanical means for eit'ecting separation of the membranes from the egg shells, a combination of chemical and mechanical means can be utilized. One convenient procedure is to agitate, in a churn or the like, water-washed, very coarsely chopped or shredded egg shells containing the adhering membranes with several times their weight of a dilute acid, for instance, a 0.25 to 4% solution in water of mineral acids such as hydrogen chloride, or a 2 to 15% solution in water of organic acids such as formic acid, or acetic acid or lactic acid or propionic acid, for a period of time, generally one to several hours, agitating until the membranes are loosened and fall away from the egg shell particles. The membranes may then be separated from the egg shell pieces by counter-current washing with water or aqueous solutions and by decantation steps. In case a small proportion of shell particles still remains attached to some membrane pieces, the membrane pieces are collected, washed with water by counter-current procedures and drained, then agitated for a period of one to four hours with a small amount of the dilute acid solution, followed by separation of the acid solution and counter-current washing of the membranes with decantation from bits of sedimented shell, using several changes of water.
The separation of the membrane from the shell may be effected with carbonic acid, that is, with an aqueous solution of carbon dioxide under pressure, though the process is time consuming. The time needed in this process may be decreased by agitating the shell pieces and by including with the shell material a cation exchange resin, for example, a cross-linked polystyrene polysulr'onic acid, in the free acidic or hydrogen form, while the shell pieces are mixed with a solution of carbon dioxide in water, under compressed carbon dioxide. In these cases the separated membranes are finally washed with water or aqueous solutions using countercurrent washing and decantation steps and the undissolved shell pieces and the cation exchange resin particles are separated with suitable sieves. The resin can then be regenerated to the free acid or hydrogen form by mineral acids, preferably hydrochloric acid, and is then ready for re-use.
In separating the membrane from the calcareous portion of the shell by means of dilute acids, separation is practically complete long before complete solution of the mineral part of the shell has taken place. It has been noted that the amount of mineral matter dissolved during the period necessary for membrane separation is much higher in the case of boiled egg shells than with uncooked egg shells, although the time of acid action is essentially the same. Evidently, boiling has created conditions in the shell which make more rapid the dissolving of the mineral matter by dilute acids.
The separated spent organic acid solutions may be regenerated for re-use conveniently by passing them through a column of appropriate cation exchange resin in acidic or hydrogen form and the cation exchange resins themselves may be regenerated to their acid forms with mineral acid solutions, such as dilute hydrochloric acid. Previous removal of the major portion of the dissolved calcium from the spent acid by the addition of sulfuric acid in amounts just insuliicient to combine with all the calcium present and subsequent separation. of the precipitated calcium sulfate by decantation and filtration, makes further regeneration of the dilute acid filtrate by treatment with cation exchange resins in and economical procedure.
Another suitable Way of eifecting separation of the membranes from the egg shells is illustrated by the foil v ing procedure. Approximately 37 grams of water-washed egg shells containing adhering membranes are chopped and placed. in an acid resistant (for example, enameled) steel pressure vessel together with. 1200 ml. of 6% w./v. acetic acid. The air in the vessel is displaced by carbon dioxide gas and then a pressure of 450 to 50% psi. of carbon dioxide gas is maintained in said vessel for one hour. The carbon dioxide is then removed and suction by vacuum means is applied to the vessel. T he suction is cut oil, applied again, and again out off. The vessel is then opened and the contents placed in a jar and agitated, any gases evolved being allowed to escape. The membranes which separated from the egg shells are removed by decantation. Repeated washing with water is followed by decantations between washings which result in effecting removal or" substantially all of the membranes from the egg shells and in removing all of the shell particles from the membranes.
The egg-shell membranes, after removal from t e egg shells, are desirably washed in water or in aqueous media. For convenience in storage or subsequent handling, it is desirable to subject them to a partial or complete drying operation depending on the physical form of the product desired from the subsequent homogenization or disintegration step. If the membranes are to be disintegrated, homogenized or pulped, for example, in a non-aqueous medium for the production of mainly non-fibrous eggshell membrane particles, a partial removal of the water contained in the washed membranes may be accomplished simply by pressing the drained membranes between absorbent surfaces, for instance bibulous paper such as blotting paper. In this form the blotter dry eggshell membranes contain about 30% by weight of membrane material, the balance being water, and they may be stored under refrigerated or freezing conditions for subsequent use in accordance with the teachings of my invention. Alternatively, the drained membranes may be dried in air or in a vacuum drier and such dried membranes may be stored for prolonged periods, indeed almost indefinitely, at room temperatures without deterioration. They may be used in this form in the subsequent disintegration or homogenization step.
The following examples are illustrative of procedures which are useful in the production of egg-sh ll membrane mainly non-fibrous products pursuant to my invention. it will be understood that various changes can be made in the li ht of the teachings disclosed herein without departing from the essential guiding principles, and particularly with respect to translating the procedures to commercial scale operations.
drogen form a more efficient Example 1 10 grams of blotter-dry mechanically separated eggshell membranes (equal to about 3 grams dried membrane) which prior to blottendrying are previously washed with water, are cut up into thin strips about 7 to A inch wide and /4 to inch long and air-dried, then placed into a laboratory ball mill containing alundum balls and ball milled until an essentially non-fibrous powder product results. Its bulk density is 0.31 gram percubic centimeter.
Example 2 A11 alpha cellulose fiber aqueous suspension prepared by homogenizing 1 gram of filter paper in 175 ml. water is poured onto a stainless steel screen box having 200 open ings to the lineal inch and the water is allowed to drain therethrough. The resulting felted mass of cellulose fibers is then sucked'down with suction and 1.2 grams of the egg-shell membrane product produced pursuant to Example 1, suspended in 175 ml. water, is poured over the surface of the felted mass of cellulose fibers. The suction is stopped and then it) ml. or" a it.% w.'/v. water solution of glycerol is carem y poured over the mass, which is in the form of a sheet, suction is then re-applied, and a top plate of aluminum is pressed do n on the sheet to force out as much liquid as possible. 7 le keeping the top plate in place, the screen box is placed in inverted position on top of a conical flask so that the weight of all is supported by the pressure of the rim of the top of the conical flask against the plate. The resulting set-up is allowed to stand overnight to allow evaporation of water through the screen interstices and the plate is then removed leaving a dry sheet of felted alpha cellulose fibers containing said e g-shell membrane product on one side. 5 Alternatmy, the suspension of alpha cellulose fibers and eggsh ll men:-
roduct produced pursuant to. Example 1 may be :ed together before pouring the mixture on the screen This results in a sheet with both sides essentially similar and with the egg-shell membrane product distributed through the sheet.
humectant so as to inhibit undue embrittlernent or drying out of the felts or sheets of th felted fibers containing said egg-shell membrane product. in place of glycerol, otl er humectants, generally aliphatic polyols, can be used, typical of which are sorbitol and propylene glycol. The humectantcan be incorporated at any suitable stage of the process.
Example 3 1 1e separated from the egg shells by the acetic acid pressure procedure described above.
Exam ole 1.5 grams of air-lri-ed very coarsely. chopped pieces strips of uncooked egg-shell membrane are put in the 250 ml. Vir Tis flask and ti en the machine is operated at 45,080 rpm. without any ice or water cooling of the k, care being taken to prevent, by careful adjustment, at no material collects in the seal at the top of the flash, acre to cause friction between the stationary cap (Teflon) and the rotating shaft cu-p (stainless steel) and so become scorched. As the operation proceeds, the pieces become Integrated progressively into smaller bits but after 15 minutes no further progress to smaller particles seems to occur. The machine is' stopped and the contents of the hash are examined. The product is a light fluffy p -ticulate material which has an apparent bulk density of 9.555 gram per cubic centimeter. The product consists mainly of pieces of egg-shell membrane and particles of egg-shell membrane but also contains numerous individual free fibers as well as a few matted agglomerates of these freed fibers. The particles are much larger than the particles obtainable by ball milling the same lrind of starting material. The freed and agglomerated fibers constitute perhaps 5% to 10% of the total product.
Example 5 1.25 grams of air-dried, very coarsely shredded or sliced pieces of uncooked egg-shell membrane are placed in the 250 ml. flash of the Vir Tis and 170ml. of 'anhydrous methyl-ethyl ltetone (Z-butanone) are added. There is no apparent softening of the crisp membrane pieces indicating little if any imb-ibition of the liquid into thev structural elements of the membrane. The Vir Tis machine is operated at gradually increasing speeds and finally for 12 minutes at 4100i) rpm. while the flash is cooled with an ice-water bath. The pieces of membrane rapidly disintegrate and in 12 minutes the agitated liquid looks like milk. It settles rapidly, however, giving a sedirent of colorless powder and a hazy supernatant of methyl-ethyl ketone. The sediment product appears to becornpesed of about equal parts of pieces of membrane and pieces of fibers. After filtration, washing out of area /s2 methyl-ethyl ket-one with dry acetone, or merely allowing the residual methyl-ethyl ketone to evaporate spontaneously from the collected disintegrated membrane material, an excellent particulate membrane material is obtained of great surface to weight ratio for the topical treatment of wounds. Bulk density of the disaggregated, air-dispersed material is 0.14 gram per cubic centimeter.
The product may also be filtered off from the methylethyl ketone and added to a water suspension of 1.0 gram of alpha-cellulose fiber pulp. The mixture may then be shaken to obtain even distribution and poured into the previously levelled screen box used for making sheets. A good serviceable sheet consisting of a mixture of alphacellulose and egg-shell membrane is readily formed in this manner, having an area of 16 square inches.
instead of removing the suspending liquid from the egg-shell membrane mainly non-fibr0us pulp suspension, the suspending liquid may be conveniently removed by subjecting the suspension of egg-shell membrane mainly non-fibrous material to commercial drying, particularly spray-drying procedures, such as are used for the recovery of heat labile solids from aqueous and other suspensions or solutions. The dry egg-shell membrane fiber aggregates resulting from the spray-drying operation may then be converted to an extremely light pulverulen-t product by subjecting these aggregates to the previously described disaggregat-ive procedure for the preparation of the extremely light pulverulent product.
I have given the above several examples which will serve to illustrate various of the many types of procedure. It is to be understood that the invention itself is not limited thereby as additional procedures will be apparent to those skilled in the art.
The following table shows the results of several experiments on egg-shell membrane disintegration utilizing various organic suspending liquids in the homogenizer. The coarsely chopped membranes in the suspending liquid were subjected to the action of the homogenizer operating at a speed of 45,000 r.p.m. Homogenization was carried out in the small receptacle using 80 ml. of liquid and the indicated quantity of air-dried membrane. The temperature was controlled by a water bath or by an ice bath around the receptacle and the contents of the receptacle were thus kept from temperatures above 50 C.
Wright of Air Time of suspending Dried Disinte- Description of Product Liquid Memgraticn, ormcd brane min. Pieces, g.
1. Anhydrous 0.75 3.5 Product consisted mainly of Pyridine; not small particles; a few fiber imbibed. pieces were seen, frequently stuck together. Some bits or pieces of membrane seen of size in microns: Large 25 x 19, SmalllG x 13. Fiber pieces 6 x 16 when moist.
2. 2:4-Pentano- 0.75 3 5 Product essentially a powdi t; dcr. A few broken bits i bib d, oi fibers sccn. Powder particles size in microns: Large 47 x 53, Small 19x38. Fiber pieces 6 x 16 when moist.
3. Chlorol'crm, 0.75 6 Product essentially a pows t der. Small particles were i bi d, 12 x 12 microns or less and numerous. Average partiole 14 x 14 microns. Largest bit 120 x 84 microns. A few fibers were seen; longest 132 microns, others 12 to 36 microns long.
The egg-shell membrane products obtained from experiments 1, 2 and 3 in the foregoing table can be effectively utilized in the preparation of the powder form or" egg-shell membrane products in the manner described above. The egg-shell membrane products shown in experiments 1, 2 and 3 in the foregoing table can be filtered off, washed with aceto .e to remove suspending liquid,
id air-dried and disaggregated and air-dispersed in the homogenizer to give the powder form of eg -shell mem brane product according to the procedure described here- The manner in which the dried egg-shell membrane particulate mainly non-fibrous materials of my invention are used to assist the healing of denuded areas on the human body is dependent, in part, on the nature of such areas. Thus, for example, if in the areas the depth to which the tissue has been lost is relatively superficial, a felted sheet containing the egg-shell membrane material in essentially non-fibrous form, or particulate eg -shell membrane product in essentially nondibrous form described above, is simply placed over said area to cover same. To this end the sheet may be cut to conform in contour to that of the area to be covered. A protective cover of hospital gauze or the like may be laid gently and preferably relatively loosely over the sheet to protect the treated lesion and to prevent contamination.
If the denuded area is quite deep, as in the case of the surgical removal of an ulcer such as a necrotic ulcer, then the area is desirably packed with the dried egg-shell membrane mainly non-fibrous material. To this end, the 100% egg-shell membrane mainly non-fibrous material can be packed or lightly tamped into the area throughout its depth. In this type of situation it is particularly desirable to pack the area with the dried egg-shell membrane material as produced in disaggregated particulate powder or non-fibrous form. The area is again protected from contamination by hospital gauze as described above. As healing proceeds, additional amounts of the dried egg-shell membrane mainly non-fibrous materials may be applied to the denuded area as may be indicated by the rate and degree of healing.
The felted fiber fabrics or sheets containing the eggshell membrane material in essentially non-fibrous form, and the egg-shell membrane powder or non-fibrous par ticulate products produced in accordance with my present invention function, when utilized in the manner described above, as protective barriers for the denuded areas, exercising a mechanical protective action as well as markedly assisting in the healing of the lesion. The body fluids present in the tissues of the lesion may become intimately admixed with the particles of the egg-shell membrane mainly non-fibrous products and on drying form a reinforced crust having considerable mechanical protective strength. Further, the enzymic substances present in such body fluids and tissue exudates may act on the said egg-shell membrane particles, presenting as they do an extensive surface area for enzyme adsorption, and such enzymic action may result in the formation of substances which facilitate the healing process and/or stimulate the growth of repair tissues and ultimately of new skin covering. The dried egg-shell membrane mainly non-fibrous products produced pursuant to my invention are characterized by exceptionally great surface area per unit of weight. This fact appears to play some role in relation to the manner in which said materials of my invention function in assisting the healing processes here involved, with due regard for the fact that the exact mechanism of the actions concerned in such processes is presently unknown.
In a typical case, an epithelioma was treated with X- rays and the resulting lesion, on the forehead of a woman, was treated by the application thereto of particulate dried uncooked egg-shell membrane product such as produced pursuant to Example 1 hereof. The lesion had a diameter of about 1 inch. Said lesion, under said treatment, was found to be completely crusted over at the end of one week, and healing of the area was complete in two weeks. Standard techniques usually require healing periods of six to seven weeks as this type of lesion is known to be very slow to heal.
It should be understood that, while it is preferred to utilize uncooked eg -shell membranes in the production mainly non-fibrous egg-shell membrane products, such as have been described herein above.
it has also been found that aqueous suspensions of the egg-shell membrane mainly non-fibrous products, prepared as described above may be treated in aqueous media with enzymes, preferably purified, of proteolytic character, such as papain, ficin, pepsin, trypsin and trypsin related enzymes, bromelin and other proteolytic enzymes of vegetable and/ or of animal origin so as to bring about partial digestion of the egg-shell membrane material. Moreover, the finished products may contain active proteolytic enzymes which serve, in certain instances, to enhance the utility of the egg-shell membrane digest product.
Useful products can also be prepared from the eg shell membrane mainly non-fibrous products herein described by oxidation and also by reduction techniques whereby to modify the disulfide linkages present in the eggshell membrane substance. Oxidations have been carried out with hydrogen peroxide, urea peroxide, perscetic acid and pertorrnic aciclto oxidize disulfide groups, presen in eggshell membrane materials, to intermediate states of oxidation of the disulfide linkages and to form cysteic acid groups. Such latter acidic groups can be reacted chemically for instance with basic amino acids such as lysine, arginine, histidine, and with methionin as well as with basic peptides. Reductions have been carried out on the egg-shell membrane particulate mainly non-fibrous products described herein With mercaptoacetic acid, mercaptopropicnic acid, substances which contain a reactive thiol group, and their soluble salts, to convert the disulfide groups present in the egg-shell membrane products to thiol groups. The resulting reduced egg-shell membrane products can then very readily be Subjected to partial digestion with proteolytic enzymes to produce modified egg-shell membrane products'useful for the treatment of denuded areas on the human body.
The dried egg-shell membrane mainly non-fibrous products, whether in sheet forms or in disaggregated particulate forms, can be sterlized, preferably prior to final packaging. This may be accomplished by techniques known in the art as, for example, by treatment with gaseous ethyl ne oxide or propylene oxide, or mixtures of each or" these gases with other gases such as mixtures of ethylene oxide gas with carbon dioxide gas, preferably under pressure and at slightly elevated temperatures, for example at 40 C. to 75 C., and at pressures of 2 to 6 atmospheres for a period of 2 to 4 hours. Sterilization may also be carried out using beta propiolactone or, in certain cases, with moist or dry heat. However, depending upon the exact manner in which the aforesaid egg-shell membrane products have been prepared and handled, they may have a practical degree of'sterility without the necessity for any special sterilizing treatments.
Further, it may beadvantageous under certain circumstances to combine the dried egg-shell membrane mainly non-fibrous products, Whether in sheet forms or in disaggregated particulate forms, with drugs, with enzymes,
with antibiotics and/or with bacteriostatic agents. To this end, said dried materials may be impregnated with the desired enzyme, drug, antibiotic or bacteriostatic substance or mixtures of these either'by mechanical admixing of the said egg-shell membrance products with the drug in dry form or the drug may be dissolved in a suitable slovent and the drug solution applied to the egg-shell membrane products at convenient points in the preparation of the eggshell membrane products herein escribes or to the finished products themselves. Typical of such antibiotics are neomycin bacitracin, and particularly, broad spectrum antibiotics such as chlortetracycline, tetracycline, oxytetracycline, chloramphenicol, sulfa drugs and others. I
While my invention is especially applicable to the 'reatment of egg-shellmembranesobtained from chicken eggs, it is also useful in relation to egg-shell membranes obtained from eggs of other birds and fowl as, for instance, duck eggs. The examples listed above were carried out with egg-shell membranes prepared from the eggs of chickens because these represent the most available sources of large supplies. of egg-shell membranes.
While 1 have d-scribed in detail processes of treating egg-shell membranes, it will be understood that other methods may be apparent to those skilled in the art.
What l claim as new and desire to protect by Letters Patent of the United States:
it. As an article of manufacture for assisting the healing of skin-denuded areas on the body, dry, finely divided pulverulent egg-shell membrane in essentially non-fibrous particle form.
2. An article of manuheture in accordance with claim l, in which the egg-shell membrane particles are derived from uncooked egg-Shell membranes.
3. As an article of manufacture for assisting the healing of skin-denude areas on the body, dry, finely divided pulverulent egg-shell membrane in essentially non-fibrous fOlnLiu-t; bulk density or" said particles in the mass being from about 0.05 to 0.40 gram per cubic centimeter.
As an article of manufacture for assisting the healing of skin-denuded areas on the body, a dry felt fiber sheet containing a finely divided egg-shell 'membrane powder in essentially non-fibrous form..
5. As an article of manufacture for assisting the healing of skindenuded areas on the body, a dry sheet comprising a layer of fiberfelt material carrying finely divided eg -shell membrane powder in essentially non-fibrous form on a fabric base member.
References Qiterl by the Examiner UNITED STATES PATENTS 2,839,312 5/36 Goldman l67-84 2,662,042 7/52 Abbott 167-65 2,833,669 5/58 Ziegler l67-S4 OTHER REFERENCES JULIAN S. LEVETT, Primary Examiner.
FRANK CACCIAPAGLEA, JR, W B. KNIGHT,
Examiners.
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3,194,732 July 13, 1965 Irene Neuhauser ppears in the above numbered pat- It is hereby certified that error a aid Letters Patent should read as ent requiring correction and that the s corrected below.
Column 1, line 66, for "now-heated" read now-healed column 4, line 42, for "compirse" read comprise column 8, line 1, for "w./v." read W/V line 50, for "0.555" read 0.055 column 9, line 72, for "products" read product column 12, line 7, for "slovent" read solvent Signed and sealed this 18th day of January 1966.
(SEAL) Attest:
ERNEST W. SWIDER Attesting Officer EDWARD J. BRENNER Commissioner of Patents
Claims (1)
- 3. AS AN ARTICLE OF MANUFACTURE FOR ASSISTING THE HEALING OF SKIN-DENUDED AREAS ON THE BODY, DRY FINELY DIVIDED PULVERULENT EGG-SHELL MEMBRANE IN ESSENTIALLY NON-FIBROUS FORM, THE BULK DENSITY OF SAID PARTICLES IN THE MASS BEING FROM ABOUT 0.05 TO 0.40 GRAM PER CUBIC CENTIMETER.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59804A US3194732A (en) | 1960-10-03 | 1960-10-03 | Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59804A US3194732A (en) | 1960-10-03 | 1960-10-03 | Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3194732A true US3194732A (en) | 1965-07-13 |
Family
ID=22025346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US59804A Expired - Lifetime US3194732A (en) | 1960-10-03 | 1960-10-03 | Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3194732A (en) |
Cited By (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3624201A (en) * | 1968-02-12 | 1971-11-30 | Lescarden Ltd | Compositions containing calcium and magnesium salts of citric, phosphoric and lactic acid and method of promoting healing of wounds therewith |
| US4219544A (en) * | 1979-02-26 | 1980-08-26 | Burg Carol J | Method for treating burns using an egg yolk oil |
| US4361552A (en) * | 1980-09-26 | 1982-11-30 | Board Of Regents, The University Of Texas System | Wound dressing |
| US4486416A (en) * | 1981-03-02 | 1984-12-04 | Soll David B | Protection of human and animal cells subject to exposure to trauma |
| US4810693A (en) * | 1985-02-08 | 1989-03-07 | Procyte Corporation | Method for inducing biological coverings in wounds |
| US4877770A (en) * | 1985-02-08 | 1989-10-31 | Procyte Corporation | Chemical derivatives of GHL-Cu |
| US4937230A (en) * | 1985-01-24 | 1990-06-26 | Procyte Corporation | Method of healing wounds in horses |
| US5023237A (en) * | 1989-08-30 | 1991-06-11 | Procyte Corporation | Methods and compositions for healing ulcers |
| US5059588A (en) * | 1989-10-13 | 1991-10-22 | Procyte Corporation, Incorporated | Methods and compositions for healing bone using gly his lys: copper |
| US5118665A (en) * | 1990-02-09 | 1992-06-02 | Procyte Corporation | Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof |
| US5120831A (en) * | 1985-02-08 | 1992-06-09 | Procyte Corporation | Metal-peptide compositions |
| US5135913A (en) * | 1987-05-11 | 1992-08-04 | Procyte Corporation | Cosmetic and skin treatment compositions |
| US5145838A (en) * | 1989-08-30 | 1992-09-08 | Procyte Corporation | Methods and compositions for healing ulcers |
| US5164367A (en) * | 1990-03-26 | 1992-11-17 | Procyte Corporation | Method of using copper(ii) containing compounds to accelerate wound healing |
| US5177061A (en) * | 1985-02-08 | 1993-01-05 | Procyte Corporation | Method for stimulating hair growth using GHL-Cu complexes |
| US5214032A (en) * | 1985-02-08 | 1993-05-25 | Procyte Corporation | GHL-CU pharmaceutical compositions and compounds |
| US5348943A (en) * | 1985-02-08 | 1994-09-20 | Procyte Corporation | Cosmetic and skin treatment compositions |
| US5538945A (en) * | 1994-06-17 | 1996-07-23 | Procyte Corporation | Stimulation of hair growth by peptide copper complexes |
| US5550183A (en) * | 1985-02-08 | 1996-08-27 | Procyte Corporation | Metal-peptide compositions and methods for stimulating hair growth |
| EP1009532A4 (en) * | 1997-03-18 | 2001-04-04 | Penn State Res Found | Waste egg shell components recovery |
| US6541447B1 (en) | 1999-09-01 | 2003-04-01 | B & M Healthcare Technologies, Inc. | Wound healing composition and method for use thereof |
| US20040180851A1 (en) * | 2003-03-12 | 2004-09-16 | New Life Resources, Llc. | Preparation of hyaluronic acid from eggshell membrane |
| US20040180025A1 (en) * | 2003-03-12 | 2004-09-16 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| US20050246840A1 (en) * | 2002-07-05 | 2005-11-10 | Idemitsu Technofine Co., Ltd. | Fiber processing agent and fiber processed with the fiber processing agent |
| US20060093540A1 (en) * | 2003-02-06 | 2006-05-04 | The Ohio State University | Separation of carbon dioxide (CO2) from gas mixtures by calcium based reaction separation (CaRS-CO2) process |
| US20060159816A1 (en) * | 2005-01-18 | 2006-07-20 | Glycon Technologies, L.L.C. | Eggshell membrane separation method |
| US20060211571A1 (en) * | 2005-03-17 | 2006-09-21 | Iyer Mahesh V | High temperature CO2 capture using engineered eggshells: a route to carbon management |
| US20070178170A1 (en) * | 2004-03-10 | 2007-08-02 | New Life Resources, Llc | Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations |
| WO2007141533A2 (en) | 2006-06-09 | 2007-12-13 | Almac Discovery Limited | Fkbp-l and uses thereof |
| US20080234195A1 (en) * | 2003-03-12 | 2008-09-25 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| US20090031691A1 (en) * | 2007-07-30 | 2009-02-05 | Takeharu Tajima | Fiber, fiber assembly, and fiber producing method |
| US20090263316A1 (en) * | 2006-09-25 | 2009-10-22 | The Ohio State University | High purity, high pressure hydrogen production with in-situ co2 and sulfur capture in a single stage reactor |
| WO2008139477A3 (en) * | 2007-05-15 | 2010-02-25 | Orka Food Technology Ltd. | System and method for separating membranes from eggshells |
| WO2012029529A1 (en) | 2010-08-31 | 2012-03-08 | 天野エンザイム株式会社 | Eggshell membrane solubilization method using enzymes |
| US8418943B2 (en) | 2005-01-18 | 2013-04-16 | Biova, L.L.C. | Egg shell membrane separation |
| US20140294961A1 (en) * | 2013-03-27 | 2014-10-02 | ALMADO Inc. | Hepatic protection agent containing eggshell membrane and pharmaceutical composition, food additive and food using the same |
| US20140356450A1 (en) * | 2013-05-28 | 2014-12-04 | ALMADO Inc. | Agent for activating sirtuin gene containing egg shell membrane ingredient and composition using the same |
| US20140363519A1 (en) * | 2013-06-11 | 2014-12-11 | The University Of Tokyo | Activator of gene expression of molecular chaperone gene comprising eggshell membrane component and composition thereof |
| JP2015084725A (en) * | 2013-10-31 | 2015-05-07 | 独立行政法人国立高等専門学校機構 | Browning or pigmentation suppression method using egg-shell membrane and browning or pigmentation suppression agent using egg-shell membrane, colorant adsorbed egg-shell membrane and egg-shell membrane powder |
| US20150150916A1 (en) * | 2013-11-29 | 2015-06-04 | The University Of Tokyo | Insulin resistance-improving agent containing eggshell membrane component, and composition using the same |
| WO2016207355A1 (en) * | 2015-06-24 | 2016-12-29 | Biovotec As | Tissue engineering scaffolds comprising particulate egg shell membrane |
| WO2017062016A1 (en) | 2015-10-08 | 2017-04-13 | Esm Technologies, Llc | METHODS FOR TREATING NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELL (NF-ĸB) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS |
| US10166260B2 (en) | 2013-05-24 | 2019-01-01 | Blaine Laboratories, Inc. | Wound care product with egg shell membrane |
| US10932952B2 (en) | 2015-11-11 | 2021-03-02 | Biovotec As | Dry biocompatible disintegratable films for delivering particulate egg shell membrane to a wound |
| AU2015340635B2 (en) * | 2014-10-28 | 2021-03-11 | Biovotec As | Micronized eggshell membrane particles and the use thereof to promote the healing of wounds |
| WO2022229326A3 (en) * | 2021-04-29 | 2023-03-23 | Avgo Biotech Ltd | Apparatus and method for producing purified calcium carbonate |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2039312A (en) * | 1935-03-15 | 1936-05-05 | Joshua H Goldman | Reenforced carded web |
| US2602042A (en) * | 1947-08-16 | 1952-07-01 | Inez M Abbott | Processing methyl cellulose and the products thereof |
| US2833669A (en) * | 1954-10-22 | 1958-05-06 | Hakle Werke Hans Klenk | Method of applying deodorising, disinfecting, fungicidal and bactericidal substances to carriers and in particular fibrous carrier substances |
-
1960
- 1960-10-03 US US59804A patent/US3194732A/en not_active Expired - Lifetime
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2039312A (en) * | 1935-03-15 | 1936-05-05 | Joshua H Goldman | Reenforced carded web |
| US2602042A (en) * | 1947-08-16 | 1952-07-01 | Inez M Abbott | Processing methyl cellulose and the products thereof |
| US2833669A (en) * | 1954-10-22 | 1958-05-06 | Hakle Werke Hans Klenk | Method of applying deodorising, disinfecting, fungicidal and bactericidal substances to carriers and in particular fibrous carrier substances |
Cited By (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3624201A (en) * | 1968-02-12 | 1971-11-30 | Lescarden Ltd | Compositions containing calcium and magnesium salts of citric, phosphoric and lactic acid and method of promoting healing of wounds therewith |
| US4219544A (en) * | 1979-02-26 | 1980-08-26 | Burg Carol J | Method for treating burns using an egg yolk oil |
| US4361552A (en) * | 1980-09-26 | 1982-11-30 | Board Of Regents, The University Of Texas System | Wound dressing |
| US4486416A (en) * | 1981-03-02 | 1984-12-04 | Soll David B | Protection of human and animal cells subject to exposure to trauma |
| US4937230A (en) * | 1985-01-24 | 1990-06-26 | Procyte Corporation | Method of healing wounds in horses |
| US4877770A (en) * | 1985-02-08 | 1989-10-31 | Procyte Corporation | Chemical derivatives of GHL-Cu |
| US5214032A (en) * | 1985-02-08 | 1993-05-25 | Procyte Corporation | GHL-CU pharmaceutical compositions and compounds |
| US4810693A (en) * | 1985-02-08 | 1989-03-07 | Procyte Corporation | Method for inducing biological coverings in wounds |
| US5550183A (en) * | 1985-02-08 | 1996-08-27 | Procyte Corporation | Metal-peptide compositions and methods for stimulating hair growth |
| US5120831A (en) * | 1985-02-08 | 1992-06-09 | Procyte Corporation | Metal-peptide compositions |
| US5348943A (en) * | 1985-02-08 | 1994-09-20 | Procyte Corporation | Cosmetic and skin treatment compositions |
| US5177061A (en) * | 1985-02-08 | 1993-01-05 | Procyte Corporation | Method for stimulating hair growth using GHL-Cu complexes |
| US5135913A (en) * | 1987-05-11 | 1992-08-04 | Procyte Corporation | Cosmetic and skin treatment compositions |
| US5023237A (en) * | 1989-08-30 | 1991-06-11 | Procyte Corporation | Methods and compositions for healing ulcers |
| US5145838A (en) * | 1989-08-30 | 1992-09-08 | Procyte Corporation | Methods and compositions for healing ulcers |
| US5059588A (en) * | 1989-10-13 | 1991-10-22 | Procyte Corporation, Incorporated | Methods and compositions for healing bone using gly his lys: copper |
| US5118665A (en) * | 1990-02-09 | 1992-06-02 | Procyte Corporation | Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof |
| US5164367A (en) * | 1990-03-26 | 1992-11-17 | Procyte Corporation | Method of using copper(ii) containing compounds to accelerate wound healing |
| US5538945A (en) * | 1994-06-17 | 1996-07-23 | Procyte Corporation | Stimulation of hair growth by peptide copper complexes |
| EP1009532A4 (en) * | 1997-03-18 | 2001-04-04 | Penn State Res Found | Waste egg shell components recovery |
| US6541447B1 (en) | 1999-09-01 | 2003-04-01 | B & M Healthcare Technologies, Inc. | Wound healing composition and method for use thereof |
| US20050246840A1 (en) * | 2002-07-05 | 2005-11-10 | Idemitsu Technofine Co., Ltd. | Fiber processing agent and fiber processed with the fiber processing agent |
| US20060093540A1 (en) * | 2003-02-06 | 2006-05-04 | The Ohio State University | Separation of carbon dioxide (CO2) from gas mixtures by calcium based reaction separation (CaRS-CO2) process |
| US8226917B2 (en) | 2003-02-06 | 2012-07-24 | The Ohio State University | Separation of carbon dioxide from gas mixtures by calcium based reaction separation |
| US7618606B2 (en) | 2003-02-06 | 2009-11-17 | The Ohio State University | Separation of carbon dioxide (CO2) from gas mixtures |
| US20080233029A1 (en) * | 2003-02-06 | 2008-09-25 | The Ohio State University | Separation of Carbon Dioxide (Co2) From Gas Mixtures By Calcium Based Reaction Separation (Cars-Co2) Process |
| US20040180025A1 (en) * | 2003-03-12 | 2004-09-16 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| US6946551B2 (en) | 2003-03-12 | 2005-09-20 | New Life Resources, Llc | Preparation of hyaluronic acid from eggshell membrane |
| US20040180851A1 (en) * | 2003-03-12 | 2004-09-16 | New Life Resources, Llc. | Preparation of hyaluronic acid from eggshell membrane |
| US20080234195A1 (en) * | 2003-03-12 | 2008-09-25 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| US8580315B2 (en) | 2004-03-10 | 2013-11-12 | Esm Technologies, Llc | Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations |
| US20070178170A1 (en) * | 2004-03-10 | 2007-08-02 | New Life Resources, Llc | Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations |
| US20090306354A1 (en) * | 2005-01-18 | 2009-12-10 | Biova, L.L.C. | Eggshell membrane separation method |
| US8056844B2 (en) | 2005-01-18 | 2011-11-15 | Biova, L.L.C. | Eggshell membrane separation method |
| US7584909B2 (en) | 2005-01-18 | 2009-09-08 | Biova, L.L.C. | Eggshell membrane separation method |
| US20060159816A1 (en) * | 2005-01-18 | 2006-07-20 | Glycon Technologies, L.L.C. | Eggshell membrane separation method |
| US20100175570A1 (en) * | 2005-01-18 | 2010-07-15 | Biova, L.L.C. | Eggshell membrane separation method |
| US8418943B2 (en) | 2005-01-18 | 2013-04-16 | Biova, L.L.C. | Egg shell membrane separation |
| US7954733B2 (en) | 2005-01-18 | 2011-06-07 | Biova, L.L.C. | Eggshell membrane separation method |
| US7678351B2 (en) | 2005-03-17 | 2010-03-16 | The Ohio State University | High temperature CO2 capture using engineered eggshells: a route to carbon management |
| US20060211571A1 (en) * | 2005-03-17 | 2006-09-21 | Iyer Mahesh V | High temperature CO2 capture using engineered eggshells: a route to carbon management |
| US9381228B2 (en) | 2006-06-09 | 2016-07-05 | Almac Discovery Limited | FKBP-L and uses thereof |
| US10577406B2 (en) | 2006-06-09 | 2020-03-03 | Almac Discovery Limited | FKBP-L polypeptides and uses in angiogenesis-mediated disorders |
| WO2007141533A2 (en) | 2006-06-09 | 2007-12-13 | Almac Discovery Limited | Fkbp-l and uses thereof |
| US20090192085A1 (en) * | 2006-06-09 | 2009-07-30 | Tracy Robson | FKBP-L And Uses Thereof |
| US7837975B2 (en) | 2006-09-25 | 2010-11-23 | The Ohio State University | High purity, high pressure hydrogen production with in-situ CO2 and sulfur capture in a single stage reactor |
| US20090263316A1 (en) * | 2006-09-25 | 2009-10-22 | The Ohio State University | High purity, high pressure hydrogen production with in-situ co2 and sulfur capture in a single stage reactor |
| US20100126912A1 (en) * | 2007-05-15 | 2010-05-27 | Eli Oren | System and method for separating membranes from eggshells |
| WO2008139477A3 (en) * | 2007-05-15 | 2010-02-25 | Orka Food Technology Ltd. | System and method for separating membranes from eggshells |
| US7767297B2 (en) * | 2007-07-30 | 2010-08-03 | Idemitsu Technofine Co., Ltd. | Fiber, fiber assembly, and fiber producing method |
| US20090031691A1 (en) * | 2007-07-30 | 2009-02-05 | Takeharu Tajima | Fiber, fiber assembly, and fiber producing method |
| WO2012029529A1 (en) | 2010-08-31 | 2012-03-08 | 天野エンザイム株式会社 | Eggshell membrane solubilization method using enzymes |
| EP2612922A4 (en) * | 2010-08-31 | 2015-12-23 | Amano Enzyme Inc | METHOD FOR SOLUBILIZING UFS SHELL MEMBRANES USING ENZYMES |
| EP2612922A1 (en) | 2010-08-31 | 2013-07-10 | Amano Enzyme Inc. | Eggshell membrane solubilization method using enzymes |
| US20140294961A1 (en) * | 2013-03-27 | 2014-10-02 | ALMADO Inc. | Hepatic protection agent containing eggshell membrane and pharmaceutical composition, food additive and food using the same |
| US10166260B2 (en) | 2013-05-24 | 2019-01-01 | Blaine Laboratories, Inc. | Wound care product with egg shell membrane |
| US20140356450A1 (en) * | 2013-05-28 | 2014-12-04 | ALMADO Inc. | Agent for activating sirtuin gene containing egg shell membrane ingredient and composition using the same |
| US20140363519A1 (en) * | 2013-06-11 | 2014-12-11 | The University Of Tokyo | Activator of gene expression of molecular chaperone gene comprising eggshell membrane component and composition thereof |
| JP2015084725A (en) * | 2013-10-31 | 2015-05-07 | 独立行政法人国立高等専門学校機構 | Browning or pigmentation suppression method using egg-shell membrane and browning or pigmentation suppression agent using egg-shell membrane, colorant adsorbed egg-shell membrane and egg-shell membrane powder |
| US20150150916A1 (en) * | 2013-11-29 | 2015-06-04 | The University Of Tokyo | Insulin resistance-improving agent containing eggshell membrane component, and composition using the same |
| US12390495B2 (en) | 2014-10-28 | 2025-08-19 | Biovotec As | Micronized eggshell membrane particles and the use thereof to promote the healing of wounds |
| US11992508B2 (en) * | 2014-10-28 | 2024-05-28 | Biovotec As | Micronized eggshell membrane particles and the use thereof to promote the healing of wounds |
| AU2015340635B2 (en) * | 2014-10-28 | 2021-03-11 | Biovotec As | Micronized eggshell membrane particles and the use thereof to promote the healing of wounds |
| US11045578B2 (en) | 2015-06-24 | 2021-06-29 | Biovotec As | Tissue engineering scaffolds comprising particulate egg shell membrane |
| CN108136073B (en) * | 2015-06-24 | 2021-02-02 | 生物科技有限公司 | Tissue engineered scaffolds comprising particulate eggshell membrane |
| CN108136073A (en) * | 2015-06-24 | 2018-06-08 | 生物科技有限公司 | Engineered stent including particle egg shell membrane |
| KR20180039046A (en) * | 2015-06-24 | 2018-04-17 | 바이오보텍 에이에스 | Tissue Engineering Scaffolds Including Particulate Oocytes |
| KR102702872B1 (en) | 2015-06-24 | 2024-09-05 | 바이오보텍 에이에스 | Tissue engineering scaffolds containing microparticle shell membrane |
| WO2016207355A1 (en) * | 2015-06-24 | 2016-12-29 | Biovotec As | Tissue engineering scaffolds comprising particulate egg shell membrane |
| WO2017062016A1 (en) | 2015-10-08 | 2017-04-13 | Esm Technologies, Llc | METHODS FOR TREATING NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELL (NF-ĸB) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS |
| US10932952B2 (en) | 2015-11-11 | 2021-03-02 | Biovotec As | Dry biocompatible disintegratable films for delivering particulate egg shell membrane to a wound |
| WO2022229326A3 (en) * | 2021-04-29 | 2023-03-23 | Avgo Biotech Ltd | Apparatus and method for producing purified calcium carbonate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3196075A (en) | Assisting healing of skin-denuded areas on the human body with dried fibrous egg-shell membrane products and compositions therefor | |
| US3742955A (en) | Fibrous collagen derived product having hemostatic and wound binding properties | |
| US3810473A (en) | Liquid-laid, non-woven, fibrous collagen derived surgical web having hemostatic and wound sealing properties | |
| US3823212A (en) | Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers | |
| Heimbach | Early burn excision and grafting | |
| JP3327540B2 (en) | Collagen product containing marine collagen with low odor and improved mechanical properties, and its use as a cosmetic or pharmaceutical composition or product | |
| CA1079635A (en) | Fibrous collagen derived web having hemostatic and wound sealing properties | |
| JPS62500630A (en) | Method for producing cellulose film as an artificial film substitute | |
| EA005697B1 (en) | A method for preparing a collagen sponge | |
| Maeda et al. | An experience of hen-egg membrane as a biological dressing | |
| JPS58212447A (en) | Production of coagulable porous collagen sheet material | |
| JP2002128691A (en) | Sericin-containing material, its production method and its use | |
| CA2143608A1 (en) | Chitosan foil for wound sealing and process for its preparation | |
| CN109486891A (en) | A kind of extraction preparation method of small molecule collagen peptide | |
| CN105797203A (en) | Alginate fiber based collagen sponge dressing and preparation method thereof | |
| CN107080856B (en) | Bacterial cellulose-chitosan-laponite composite wound dressing and preparation method thereof | |
| CN108553329A (en) | A kind of facial mask liquid, facial mask and preparation method thereof | |
| CN110339391A (en) | Hemostatic material of novel degradable and preparation method thereof | |
| CN107137758A (en) | A kind of microfibrillar collagen hemostatic material and preparation method thereof | |
| CN106806063A (en) | A kind of medical dressing and its preparation technology containing nano-chitosan | |
| US5820874A (en) | Alginate fibres, method of preparation and use | |
| CN100376247C (en) | Preparation of bio-membrane in use for promoting wound healing, and preparation method | |
| CN110302415A (en) | A kind of preparation method of high bond strength moisture-inhibiting promoting healing wound dressing | |
| JPH06254149A (en) | Sheet material | |
| CN114099761B (en) | A kind of bath sponge hemostatic material and its preparation method and application |